Eptacog Alfa (biosimilar)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Eptacog Alfa (biosimilar), covering 2021-02-04 to 2021-02-04. Get the full timeline:
Most recent: Clinical Trial Update: Study Comparing the Pharmacokinetic of Biosimilar Eptacog Alfa With Novoseven®, in Patients With Congenital Factor VII Deficiency [Phase 3]